New insights into biological markers of frontotemporal lobar degeneration spectrum

Current Medicinal Chemistry

Volumn 17, Issue 10, 2010, Pages 1002-1009

  Borroni, Barbara ^a   Alberici, Antonella ^a   Archetti, Silvana ^b   Magnani, Enrico ^a   Di Luca, Monica ^c   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Brescia Hospital   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Biomarkers; Cerebrospinal fluid; Corticobasal degeneration syndrome; Frontotemporal dementia; Frontotemporal lobar degeneration; Progranulin; Progressive supranuclear palsy; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CYSTATIN C; NEUROFILAMENT LIGHT CHAIN; OREXIN A; PROGRANULIN; TAU PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

BIOACCUMULATION; CEREBROSPINAL FLUID; DIAGNOSTIC ACCURACY; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; NEUROPATHOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW;

BIOLOGICAL MARKERS; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 77950650643     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790820651     Document Type: Review

References (64)

1. Snowden, J.S.; Neary, D.; Mann, D.M. Frontotemporal dementia. Br. J. Psychiatry., 2002, 180, 140-143
2. Davies, R.R.; Kipps, C.M.; Mitchell, J.; Kril, J.J.; Halliday, G.M.; Hodges, J.R. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch. Neurol., 2006, 63(11),1627-1631
3. Ratnavalli, E.; Brayne, C.; Dawson, K.; Hodges, J.R. The prevalence of frontotemporal dementia. Neurology, 2002, 58, 1615-1621
4. Gislason, T.B.; Sjögren, M.; Larsson, L.; Skoog, I. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds. J. Neurol. Neurosurg. Psychiatry, 2003, 74, 867-871 (Pubitemid 36782985)
5. Rosso, S.M.; Donker Kaat, L.; Baks, T.; Joosse, M.; de Koning, I.; Pijnenburg, Y.; de Jong, D.; Dooijes, D.; Kamphorst, W.; Ravid, R.; Niermeijer, M.F.; Verheij, F.; Kremer, H.P.; Scheltens, P.; van Duijn, C.M.; Heutink, P.; van Swieten, J.C. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain, 2003, 126, 2016-2022
6. Neary, D.; Snowden, J.S.; Gustafson, L.; Passant, U.; Stuss, D.; Black, S.; Freedman, M.; Kertesz, A.; Robert, P.H.; Albert, M.; Boone, K.; Miller, B.L.; Cummings, J.; Benson, D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 1998, 51(6), 1546-1554 (Pubitemid 28565230)
7. McKhann, G.M.; Albert, M.S.; Grossman, M.; Miller, B.; Dickson, D.; Trojanowski, J.Q.; WorkGroup on Frontotemporal Dementia and Pick's Disease. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch. Neurol., 2001, 58, 1803-1809
8. Lomen-Hoerth, C.; Anderson, T.; Miller, B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology, 2002, 59, 1077-1079.
9. Kertesz, A.; Munoz, D.G.; Hillis, A. Preferred Terminology. Ann. Neurol., 2003, 54(Suppl 5), S3-S6.
10. Cairns, N.J.; Bigio, E.H.; Mackenzie, I.R.; Neumann, M.; Lee, V.M.; Hatanpaa, K.J.; White, C.L. 3rd; Schneider, J.A.; Grinberg, L.T.; Halliday, G.; Duyckaerts, C.; Lowe, J.S.; Holm, I.E.; Tolnay, M.; Okamoto, K.; Yokoo, H.; Murayama, S.; Woulfe, J.; Munoz, D.G.; Dickson, D.W.; Ince, P.G.; Trojanowski, J.Q.; Mann, D.M.; Consortium for Frontotemporal Lobar Degeneration. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. (Berl), 2007, 114, 5-22.
11. Neumann, M.; Sampathu, D.M.; Kwong, L.K.; Truax, A.C.; Micsenyi, M.C.; Chou, T.T.; Bruce, J.; Schuck, T.; Grossman, M.; Clark, C. M.; McCluskey, L. F.; Miller, B. L.; Masliah, E.; Mackenzie, I. R.; Feldman, H.; Feiden, W.; Kretzschmar, H. A.; Trojanowski, J. Q.; Lee, V. M.-Y. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 2006, 314,130-133 (Pubitemid 44547757)
12. Stevens, M.; van Duijn, C.M.; Kamphorst, W.; de Knijff, P.; Heutink, P.; van Gool, W.A.; Scheltens, P.; Ravid, R.; Oostra, B.A.; Niermeijer, M.F.; van Swieten, J.C. Familial aggregation in frontotemporal dementia. Neurology, 1998, 50, 1541-1545
13. Brown, J.; Ashworth, A.; Gydesen, S.; Sorensen, A.; Rossor, M.; Hardy, J.; Collinge, J. Familial non-specific dementia maps to chromosome 3. Hum. Mol. Genet., 1995, 4, 1625-1628
14. Hosler, B.A.; Siddique, T.; Sapp, P.C.; Sailor, W.; Huang, M.C.; Hossain, A.; Daube, J.R.; Nance, M.; Fan, C.; Kaplan, J.; Hung, W.Y.; McKenna-Yasek, D.; Haines, J.L.; Pericak-Vance, M.A.; Horvitz, H.R.; Brown, R.H. Jr. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA, 2000, 284(13), 1664-1669
15. Morita, M.; Al-Chalabi, A.; Andersen, P.M.; Hosler, B.; Sapp, P.; Englund, E.; Mitchell, J.E.; Habgood, J.J.; de Belleroche, J.; Xi, J.; Jongjaroenprasert, W.; Horvitz H.R.; Gunnarsson, L.G.; Brown, R.H. Jr. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology, 2006, 66(6), 839-844
16. Vance, C.; Al-Chalabi, A.; Ruddy, D.; Smith, B.N.; Hu, X.; Sreedharan, J.; Siddique, T.; Schelhaas, H.J.; Kusters, B.; Troost, D.; Baas, F.; de Jong, V.; Shaw, C.E. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain, 2006,129, 868-876
17. Hutton, M.; Lendon, C.; Rizzu, P.; Baker, M.; Froelich, S.; Houlden, H.; Pickering-Brown, S.; Chakraverty, S.; Isaacs, A.; Grover, A.; Hackett, J.; Adamson, J.; Lincoln, S.; Dickson, D.; Davies, P.; Petersen, R.C.; Stevens, M.; de Graaff, E.; Wauters, E.; van Baren, J.; Hillebrand, M.; Joosse, M.; Kwon, J.M.; Nowotny, P.; Che, L.K.; Norton, J.; Morris, J.C.; Reed L.A.; Trojanowski, J.; Basun, H.; Lannfelt, L.; Neystat, M.; Fahn, S.; Dark, F.; Tannenberg, T.; Dodd, P.R.; Hayward, N.; Kwok, J.B.; Schofield, P.R.; Andreadis, A.; Snowden, J.; Craufurd, D.; Neary, D.; Owen, F.; Oostra, B.A.; Hardy, J.; Goate, A.; van Swieten, J.; Mann, D.; Lynch, T.; Heutink, P. Association of missense and 59-splice-site mutations in tau with inherited dementia FTDP-17. Nature, 1998, 393,702-705. (Pubitemid 28289662)
18. van Swieten, J.; Spillantini, M.G. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain. Pathol., 2007, 17(1), 63-73. (Pubitemid 46310686)
19. Skibinski, G.; Parkinson, N.J.; Brown, J.M.; Chakrabarti, L.; Lloyd, S.L.; Hummerich, H.; Nielsen, J.E.; Hodges, J.R.; Spillantini, M.G.; Thusgaard, T.; Brandner, S.; Brun, A.; Rossor, M.N.; Gade, A.; Johannsen, P.; Sørensen, S.A.; Gydesen, S.; Fisher, E.M.; Collinge, J. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet., 2005, 37, 806-808. (Pubitemid 41077105)
20. Watts, G.D.; Wymer, J.; Kovach, M.J.; Mehta, S.G.; Mumm, S.; Darvish, D.; Pestronk, A.; Whyte, M.P.; Kimonis, V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet., 2004, 36: 377-381
21. Cruts, M.; Gijselinck, I.; van der Zee, J.; Engelborghs, S.; Wils, H.; Pirici, D.; Rademakers, R.; Vandenberghe, R.; Dermaut, B.; Martin, J.J.; van Duijn, C.; Peeters, K.; Sciot, R.; Santens, P.; De Pooter, T.; Mattheijssens, M.; Van den Broeck, M.; Cuijt, I.; Vennekens, K.; De Deyn, P.P.; Kumar-Singh, S.; Van Broeckhoven, C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 2006, 442, 920-924. (Pubitemid 44285947)
22. Baker, M.; Mackenzie, I.R.; Pickering-Brown, S.M.; Gass, J.; Rademakers, R.; Lindholm, C.; Snowden, J.; Adamson, J.; Sadovnick, A.D.; Rollinson, S.; Cannon, A.; Dwosh, E.; Neary, D.; Melquist, S.; Richardson, A.; Dickson, D.; Berger, Z.; Eriksen, J.; Robinson, T.; Zehr, C.; Dickey, C.A.; Crook, R.; McGowan, E.; Mann, D.; Boeve, B.; Feldman, H.; Hutton, M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature, 2006, 442, 916-919. (Pubitemid 44285946)
23. Van Damme, P.; Van Hoecke, A.; Lambrechts, D.; Vanacker, P.; Bogaert, E.; van Swieten, J.; Carmeliet, P.; Van Den Bosch, L.; Robberecht, W. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J. Cell Biol., 2008, 181(1), 37. (Pubitemid 351519762)
24. Eriksen, J.L.; Mackenzie, I.R. Progranulin: normal function and role in neurodegeneration. J. Neurochem., 2008, 104(2), 287-297
25. Kabashi, E.; Valdmanis, P.N.; Dion, P.; Spiegelman, D.; McConkey, B.J.; Vande Velde, C.; Bouchard, J.-P.; Lacomblez, L.; Pochigaeva, K.; Salachas, F.; Pradat, P.-F.; Camu, W.; Meininger, V.; Dupre, N.; Rouleau, G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet., 2008, 40, 572-574. (Pubitemid 351601218)
26. Sreedharan, J.; Blair, I.P.; Tripathi, V.B.; Hu, X.; Vance, C.; Rogelj, B.; Ackerley, S.; Durnall, J. C.; Williams, K. L.; Buratti, E.; Baralle, F.; de Belleroche, J.; Mitchell, J.D.; Leigh, P. N.; Al-Chalabi, A.; Miller, C.C.; Nicholson, G.; Shaw, C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 2008, 319, 1668-1672 (Pubitemid 351432505)
27. Cook, C.; Zhang, Y.J.; Xu, Y.F.; Dickson, D.W.; Petrucelli, L. TDP-43 in neurodegenerative disorders. Expert. Opin. Biol. Ther., 2008, 8, 969-978
28. Dickson, D.W. TDP-43 immunoreactivity in neurodegenerative disorders: disease versus mechanism specificity. Acta Neuropathol., 2008, 115, 147-149.
29. Rutherford, N.J.; Zhang, Y.J.; Baker, M.; Gass, J.M.; Finch, N.A.; Xu, Y.F.; Stewart, H.; Kelley, B.J.; Kuntz, K.; Crook, R.J.; Sreedharan, J.; Vance, C.; Sorenson, E.; Lippa, C.; Bigio, E.H.; Geschwind, D.H.; Knopman, D.S.; Mitsumoto, H.; Petersen, R.C.; Cashman, NR.; Hutton, M.; Shaw, C.E.; Boylan, K.B.; Boeve, B.; Graff-Radford, N.R.; Wszolek, Z.K.; Caselli, R.J.; Dickson, D.W.; Mackenzie, I.R.; Petrucelli, L.; Rademakers, R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet., 2008, 4, e1000193.
30. Kovacs, G.G.; Murrell, J.R.; Horvath, S.; Haraszti, L.; Majtenyi, K.; Molnar, M.J.; Budka, H., Ghetti, B.; Spina, S. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord., 2009, 24, 1843-1847.
31. Borroni, B.; Bonvicini, C.; Alberici, A.; Buratti, E.; Agosti, C.; Archetti, S.; Papetti, A.; Stuani, C.; Di Luca, M.; Gennarelli, M.; Padovani, A. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat., 2009, E974-983.
32. Vance, C.; Rogelj, B.; Hortobágyi, T.; De Vos, K.J.; Nishimura, A.L.; Sreedharan, J.; Hu, X.; Smith, B.; Ruddy, D.; Wright, P.; Ganesalingam, J.; Williams, K.L.; Tripathi, V.; Al-Saraj, S.; Al-Chalabi, A.; Leigh, P.N.; Blair, I.P.; Nicholson, G.; de Belleroche, J.; Gallo, J.M.; Miller, C.C.; Shaw, C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 2009, 323, 1208-1211.
33. Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H.A., Mackenzie, I.R. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain, 2009, 132, 2922-2931.
34. Ghidoni, R.; Benussi, L.; Glionna, M.; Franzoni, M.; Binetti, G. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology, 2008, 71(16), 1235-1239
35. Finch, N.; Baker, M.; Crook, R.; Swanson, K.; Kuntz, K.; Surtees, R.; Bisceglio, G.; Rovelet-Lecrux, A.; Boeve, B.; Petersen, R.C.; Dickson, D.W.; Younkin, S.G.; Deramecourt, V.; Crook, J.; Graff-Radford, N.R.; Rademakers, R. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain, 2009, 132(Pt 3), 583-591
36. Sleegers, K.; Brouwers, N.; Van Damme, P.; Engelborghs, S.; Gijselinck, I.; van der Zee, J.; Peeters, K.; Mattheijssens, M.; Cruts, M.; Vandenberghe, R.; De Deyn, P.P.; Robberecht, W.; Van Broeckhoven, C. Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann. Neurol., 2009, 65(5), 603-609
37. Arai, H.; Morikawa, Y.; Higuchi, M.; Matsui, T.; Clark, C.M.; Miura, M.; Machida, N.; Lee, V.M.; Trojanowski, J.Q.; Sasaki, H. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys. Res. Commun., 1997, 236(2), 262-264 (Pubitemid 27373280)
38. Green, A.J.; Harvey, R.J.; Thompson, E.J.; Rossor, M.N. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease. Neurosci. Lett., 1999, 259(2), 133-135 (Pubitemid 29064148)
39. Riemenschneider, M.; Wagenpfeil, S.; Diehl, J.; Lautenschlager, N.; Theml, T.; Heldmann, B.; Drzezga, A.; Jahn, T.; Förstl, H.; Kurz, A. Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology, 2002, 58(11), 1622-1628 (Pubitemid 34602892)
40. Mecocci, P.; Cherubini, A.; Bregnocchi, M.; Chionne, F.; Cecchetti, R.; Lowenthal, D.T.; Senin, U. Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?. Alzheimer. Dis. Assoc. Disord., 1998, 12(3), 211-214 (Pubitemid 29154992)
41. Grossman, M.; Farmer, J.; Leight, S.; Work, M.; Moore, P.; Van Deerlin, V.; Pratico, D.; Clark, C.M.; Coslett, H.B.; Chatterjee, A.; Gee, J.; Trojanowski, J.Q.; Lee, VM. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann. Neurol., 2005, 57(5), 721-729 (Pubitemid 40628861)
42. Kapaki, E.; Paraskevas, G.P.; Papageorgiou, S.G.; Bonakis, A.; Kalfakis, N.; Zalonis, I.; Vassilopoulos, D. Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord., 2008, 22(1), 47-53. (Pubitemid 351651397)
43. Pijnenburg, Y.A.; Schoonenboom, N.S.; Rosso, S.M.; Mulder, C.; Van Kamp, G.J.; Van Swieten, J.C.; Scheltens, P. CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration. Neurology, 2004, 62(9), 1649. (Pubitemid 38608224)
44. Bian, H.; Van Swieten, J.C.; Leight, S.; Massimo, L.; Wood, E.; Forman, M.; Moore, P.; de Koning, I.; Clark, C.M.; Rosso, S.; Trojanowski, J.; Lee, V.M.; Grossman, M. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology, 2008, 70(19 Pt 2), 1827-1835 (Pubitemid 351653951)
45. Pijnenburg, Y.A.; Schoonenboom, S.N.; Barkhof, F.; Knol, D.L.; Mulder, C.; Van Kamp, G.J.; Van Swieten, J.C.; Scheltens, P. CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging. J. Neurol. Neurosurg. Psychiatry, 2006, 77(2), 246-248 (Pubitemid 43220853)
46. Borroni, B.; Di Luca, M.; Padovani, A. Tau haplotype affects CSF Tau levels in frontotemporal dementia: implication for diagnostic purposes. J. Neurol., 2006, 253(7), 946. (Pubitemid 44100452)
47. Simonsen, A.H.; McGuire, J.; Podust, V.N.; Hagnelius, N.O.; Nilsson, T.K.; Kapaki, E.; Vassilopoulos, D.; Waldemar, G. A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement. Geriatr. Cogn. Disord., 2007, 24(6), 434-440 (Pubitemid 350175903)
48. Rüetschi, U.; Zetterberg, H.; Podust, V.N.; Gottfries, J.; Li, S.; Hviid Simonsen, A.; McGuire, J.; Karlsson, M.; Rymo, L.; Davies, H.; Minthon, L.; Blennow, K. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp. Neurol., 2005, 196(2), 273-281 (Pubitemid 41607815)
49. Bibl, M.; Mollenhauer, B.; Lewczuk, P.; Esselmann, H.; Wolf, S.; Trenkwalder, C.; Otto, M.; Stiens, G.; Rüther, E.; Kornhuber, J.; Wiltfang, J. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Mol. Psychiatry, 2007, 12(7), 671-680 (Pubitemid 46998250)
50. Steele, J.C.; Richardson, J.C.; Olszewski, J. Progressive Supranuclear Palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol., 1964, 10, 333-359
51. Litvan, I.; Agid, Y.; Goetz, C.; Jankovic, J.; Wenning, G.K.; Brandel, J.P.; Lai, E.C.; Verny, M.; Ray-Chaudhuri, K.; McKee, A.; Jellinger, K.; Pearce, R.K.; Bartko, J.J. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology, 1997, 48(1), 119-125 (Pubitemid 27039529)
52. Osaki, Y.; Ben-Shlomo, Y.; Lees, A.J.; Daniel, S.E.; Colosimo, C.; Wenning, G.; Quinn, N. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov. Disord., 2004, 19(2), 181-189 (Pubitemid 38312700)
53. Hughes, A.J.; Daniel, S.E.; Ben-Shlomo, Y.; Lees, A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain, 2002, 125(Pt 4), 861-870
54. Urakami, K.; Wada, K.,; Arai, H.; Sasaki, H.; Kanai, M.; Shoji, M.; Ishizu, H.; Kashihara, K.; Yamamoto, M.; Tsuchiya-Ikemoto, K.; Morimatsu, M.; Takashima, H.; Nakagawa, M.; Kurokawa, K.; Maruyama, H.; Kaseda, Y.; Nakamura, S.; Hasegawa, K.; Oono, H.; Hikasa, C.; Ikeda, K.; Yamagata, K.; Wakutani, Y.; Takeshima, T.; Nakashima, K. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J. Neurol. Sci., 2001, 183(1), 95-98 (Pubitemid 32141077)
55. Mitani, K.; Furiya, Y.; Uchihara, T.; Ishii, K.; Yamanouchi, H.; Mizusawa, H.; Mori, H. Increased CSF tau protein in corticobasal degeneration. J. Neurol., 1998, 245(1), 44-46 (Pubitemid 28118860)
56. Noguchi, M.; Yoshita, M.; Matsumoto, Y.; Ono, K.; Iwasa, K.; Yamada, M. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. J. Neurol. Sci., 2005, 237(1-2), 61-65 (Pubitemid 41384015)
57. Paraskevas, G.P.; Kapaki, E.; Liappas, I.; Theotoka, I.; Mamali, I.; Zournas, C.; Lykouras, L. The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders. J. Geriatr. Psychiatry Neurol., 2005, 18(3), 163-173 (Pubitemid 41284967)
58. Borroni, B.; Gardoni, F.; Parnetti, L.; Magno, L.; Malinverno, M.; Saggese, E.; Calabresi, P.; Spillantini, M.G.; Padovani, A.; Di Luca, M. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol. Aging., 2009, 30(1), 34-40.
59. Brettschneider, J.; Petzold, A.; Süssmuth, S.D.; Landwehrmeyer, G.B.; Ludolph, A.C.; Kassubek, J.; Tumani, H. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov. Disord., 2006, 21(12), 2224-2227 (Pubitemid 46140444)
60. Verbeek, M.M.; Abdo, W.F.; De Jong, D.; Horstink, M.W.; Kremer, B.P.; Bloem, B.R. Cerebrospinal fluid Abeta42 levels in multiple system atrophy. Mov. Disord., 2004, 19(2), 238-240
61. Holmberg, B.; Johnels, B.; Blennow, K.; Rosengren, L. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy. Mov. Disord., 2003, 18(2), 186-190 (Pubitemid 36305463)
62. Yasui, K.; Inoue, Y.; Kanbayashi, T.; Nomura, T.; Kusumi, M.; Nakashima, K. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J. Neurol. Sci., 2006, 250(1-2), 120-123 (Pubitemid 44665944)
63. Constantinescu, R.; Zetterberg, H.; Holmberg, B.; Rosengren, L. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders. Parkinsonism Relat. Disord., 2009, 15(3), 205-212
64. Borroni, B.; Malinverno, M.; Gardoni, F.; Alberici, A.; Parnetti, L.; Premi, E.; Bonuccelli, U.; Grassi, M.; Perani, D.; Calabresi, P.; Di Luca, M.; Padovani, A. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology, 2008, 71(22), 1796-1803